ChengDu ShengNuo Biotec Co.,Ltd. (SHA:688117)
China
· Delayed Price · Currency is CNY 38.80
+0.50 (1.31%)
Mar 10, 2026, 3:00 PM CST
ChengDu ShengNuo Biotec Company Description
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs.
The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate.
ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.
ChengDu ShengNuo Biotec Co.,Ltd.
| Country | China |
| Founded | 2001 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,450 |
| CEO | Yongjun Wen |
Contact Details
Address: No. 98, Da'an Road, Dayi County Chengdu, Sichuan Province 611330 China | |
| Phone | 86 28 8820 3630 |
| Website | snbiopharm.com |
Stock Details
| Ticker Symbol | 688117 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000051M8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Yongjun Wen | Chairman and GM |
| Li Wu | Chief Financial Officer, Deputy GM and Director |
| Xiaoli Wang | Director and Deputy General Manager |
| Xiaohai Yu | Deputy GM, Board Secretary and Director |
| Changliang Lu | Deputy General Manager |
| Zhonggang Ma | Deputy General Manager |
| Yang Shi | Accounting Supervisor |